For other health needs, explore our specialized programs, including Signature Wellness, Gut Care Program, Pregnancy Care, Hormonal Care Program, Cancer Care, Balanced Nutrition for Children.and GLP-1 Drug Lifestyle & Support Program
Although its likely the UK will approve tirzepatide in the not-to-distant future
This content is not a substitute for professional medical advice or diagnosis
Summary: No GLP-1 transdermal patches are currently licensed for use in the UK
Common gastrointestinal side effects (nausea, vomiting, diarrhoea) typically diminish within 48 weeks
Liraglutide (Saxenda) was one of the earlier forms of longer-lasting GLP-1s and reduces HbA1c (average blood glucose) levels by around 1.3% on average and fasting plasma glucose by 2 mmol/L